Medicines Formulary - search results for ""

Search results for ""

Drug name	NICE TAs	Comments	Subchapter
Gelofusine infusion			9.2
Gemcitabine injection	TA116 - Gemcitabine for the treatment of metastatic breast cancer TA25 - Guidance on the use of gemcitabine for the treatment of pancreatic cancer TA285 - Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer TA476 - Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cance	Negative TA. Hospital use only.	8.1
Gemeprost			7.1
Gemtuzumab ozogamicin	TA545 - Gemtuzumab ozogamicin for untreated acute myeloid leukaemia		8.2
Gentamicin 0.3% drops (ophthalmic)		Second line after chloramphenicol - specialist ophthalmologist recommendation.	11.3
Gentamicin ear drops		Only with positive culture/sensitivity data	12.1
Gentamicin nebulised		Hospital only	3.7
Gentisone HC ear drops		Only with positive cultures/sensitivity data	12.1
Glatiramer acetate (Copaxone®)	TA527 - Beta interferons and glatiramer acetate for treating multiple sclerosis		8.1
Glatiramer injection	TA254 - Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis TA527 - Beta interferons and glatiramer acetate for treating multiple sclerosis		8.2

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.